SYED SHAHAB: Open Payments
NPI 1912940123 · HOWELL, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,716 in 94 payments from 16 companies in 2025. Trend: 2023 $1,072 · 2024 $1,318 · 2025 $1,716
Food & beverage: $1,716
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $283 |
| Novo Nordisk Inc | 16 | $280 |
| PFIZER INC. | 13 | $211 |
| Lilly USA, LLC | 10 | $177 |
| Otsuka America Pharmaceutical, Inc. | 12 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $168 |
| Exact Sciences Corporation | 4 | $101 |
| Amgen Inc. | 4 | $73 |
| Sumitomo Pharma America, Inc. | 2 | $57 |
| Alexion Pharmaceuticals, Inc. | 2 | $55 |
Products named: REXULTI, Kerendia, MOUNJARO, Wegovy, ELIQUIS, Cologuard Collection Kit, AIRSUPRA, Rybelsus.
Industry payments across MI — which companies pay providers there.
